- Member Center
- Professional Groups
|The 2012 IP100 Executive Forum Speakers|
The 2012 IP100 Executive Forum
Dr. Alph Bingham is a pioneer in the field of open innovation and an advocate of collaborative approaches to research and development. He is co-founder, and former president and chief executive officer of InnoCentive Inc., a web-based community that matches companies facing R&D challenges with scientists who propose solutions. Through InnoCentive, a platform that leverages the ability to connect to a whole planet of people through the Internet, organizations can access individuals–problem solvers–who might never have been found. Alph's newly released book, The Open Innovation Marketplace, introduces groundbreaking strategies and models for leveraging the world's best innovation sources to drive far more value from new products, services, and business models–and do it with far less risk.
Alph spent more than 25 years with Eli Lilly and Company, and offers deep experience in pharmaceutical research and development, research acquisitions and collaborations, and R&D strategic planning. During his career he was instrumental in creating and developing Eli Lilly's portfolio management process as well as establishing the divisions of Research Acquisitions, the Office of Alliance Management, and e.Lilly, a business innovation unit, from which various other ventures that create the advantages of open and networked organizational structures, including: InnoCentive, YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc.
He currently serves on the Board of Directors of InnoCentive, Inc., and Collaborative Drug Discovery, Inc.; the advisory boards of the Center for Collective Intelligence (MIT), the Business Innovation Factory, and Coalesix, Inc. and as a member of the board of trustees of the Bankinter Foundation in Madrid.
He has lectured extensively at both national and international events and serves as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. He is also the former chairman of the Board of Editors of the Research Technology Management Journal. Dr. Bingham was the recipient of The Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive. He was also named as one of Project Management Institute's "Power 50" leaders in October 2005.
Dr. Bingham received a Ph.D. in organic chemistry from Stanford University.
She leads a team of around 200 highly experienced IP professionals located in 13 sites in Europe, US and Asia. The yearly revenues of her activity amount to more than 400 million Euros per year.
Prior to this and since 1993, she led Patent and Licensing operations at Thomson, allowing the business to grow significantly during that period.
From 1984 to 1992, Mrs. Béatrix de Russé was in charge of international contracts and Intellectual Property at Thomson Components and STMicroelectronics, where she specialized in Intellectual Property matters.
From 1976 to 1983, she worked as an international attorney at the international division of Thales (former Thomson CSF).
Mrs. Béatrix de Russé holds a Master’s degree in law and DESS in International Trade law as well as a Master’s degree in English and a CDCI diploma.
Kathleen A. Denis, PhD, CLP
Kathleen A. Denis, PhD, CLP is the Associate Vice President of Technology Transfer at The Rockefeller University, a premier biomedical research institution located in New York City. She is a Past President of the Licensing Executives Society USA/Canada (LES), and has served on the Board of Directors of the Association of University Technology Managers (AUTM) and the Pennsylvania Biotechnology Association. She is a Certified Licensing Professional, a former Chair of the Board of Governors of Certified Licensing Professionals, Inc. and a Registered Technology Transfer Professional (RTTP).
Specializing in the management of intellectual assets in the life sciences, she has worked with academic institutions and industry clients to manage intellectual property portfolios, evaluate new technologies, market and license technologies and start new technology-based businesses. Dr. Denis is active in numerous professional organizations and speaks frequently about early stage technology evaluation, formation of start-up companies, conflict of interest and other issues of academic technology transfer.
Dr. Denis holds a Ph.D. in immunology from the University of Pennsylvania, an M.A. in Human Genetics from University of Texas Medical Branch at Galveston and an undergraduate degree in genetics from Cornell University.
William C. Elkington
Bill is Senior Director, Intellectual Property Management, at Rockwell Collins. He is responsible for protection, value extraction, and rights management strategies concerning Rockwell Collins's strategic intellectual property. His group works with the company's business units to value IP and to structure both upstream and downstream licenses in the normal course of its business. He has held this position since 2003.
Bill is on the Board of Trustees for the Licensing Executives Society, with a special assignment in the area of corporate communications. He is Chair of the IP100 Executive Forum Committee, which sponsors an annual invitation-only meeting for IP management thought leaders from IP-owner organizations.
Prior to joining Rockwell Collins, Bill was co-founder and VP of Program Management at MeshNetworks, a wireless startup company established to commercialize ITT's novel communication technology. MeshNetworks was sold to Motorola in 2004.
Prior to joining MeshNetworks, Bill held positions in IP management, technology marketing, strategic and operations planning, and program management in ITT's Aerospace/Communications Division (A/CD) and GE R&D organizations.
Bill is a Phi Beta Kappa graduate of the University of Michigan, and his advanced degrees are from Syracuse University.
Lesley Millar has served as the Director of the Office of Technology Management (OTM) at the University of Illinois at Urbana-Champaign since 2006; she originally joined the Office in 2002 as an Engineering Technology Manager. As Director, Ms. Millar leads a team of more than 20 professionals responsible for the identification, protection, marketing and licensing of intellectual property arising from the more than $400 million in research conducted on campus. She also works with a wide range of campus, corporate, and community partners, furthering the office's mission to encourage innovation, enhance research and facilitate economic development. Prior to joining the OTM, Ms. Millar had an extensive career in government in England where she worked in consulting, contract and small business management, strategic planning, and policy development.
Ms. Millar is a frequent speaker at technology transfer seminars and professional meetings. She is on the Editorial Advisory Board of Intellectual Property Marketing Advisor Publication and is a regular contributor to articles and webinars for Technology Transfer Tactics. She is a member of both the Licensing Executive Society and Association of University Technology Managers. A native of Scotland, Ms. Millar has a B.Ed. an M.Ed and an MBA. She is also a Certified Licensing Professional (CLP).
Joshua Salisbury is a Managing Director with AMV. Prior to AMV, Joshua was a Managing Director at DRI Capital, a $1 billion healthcare private equity fund based in Toronto, Canada. Joshua joined DRI Capital in March 2007.
Prior to that he served as Vice President of Corporate Business Development and a member of Senior Management at Eli Lilly, where he had responsibility for all phases of group business development including managing Eli Lilly's $200MM venture capital fund, M&A, technology in-licensing, outpartnering and royalty monetization. Joshua was previously a Managing Director and Head of the Medical Technology Group at Morgan Stanley and prior to that he held the same position at Merrill Lynch. Before Merrill Lynch, Joshua worked as an investment banker at Wasserstein, Perella. He holds a BA from the University of Chicago in economics, and an MBA with honors from Harvard Business School.
Jim Sledzik, partner and president of U.S. office at Energy Ventures, has more than 21 years of experience in the oil and gas industry worldwide. Sledzik serves on the board of directors of five Energy Ventures investments (Ingrain, Oxane, Arkex, FFA and Wireless Seismic). Prior to joining Energy Ventures, Sledzik was the vice president of marketing and new technology at WesternGeco in London. He has also served as the vice president of global multiclient services for WesternGeco and a global account director at Schlumberger. Sledzik received an MBA in International Business from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh, and earned his Bachelor of Science in Geosciences at Penn State University.